IsoTis Acquires GenSci OrthoBiologics

Swiss company, IsoTis SA, acquired GenSci OrthoBiologics, Inc. for $75 million on October 27, 2003. GenSci was the wholly owned U.S. subsidiary of Mississauga, Ontario-based GenSci Regeneration Sciences Inc. The acquisition was carried out through a plan of arrangement under the B.C. Company Act. The newly combined companies will create a dedicated and global player in the field of orthobiologics.

IsoTis’s in-house legal team was led by Pieter Wolters, CFO, and Nakisa Serry, counsel; in Canada by Lang Michener LLP in Vancouver, with a team led by Stephen Wortley (mergers & acquisitions), Tracey Gibb (securities), and Philippe Tardif (securities) in Toronto, Peter Botz (tax) and Jeff Sheremeta and Amandeep Sandhu (securities); in the U.S. by Cravath, Swaine & Moore LLP, with a team that included Peter Wilson, Michael Silverberg, Stefan Padfield, Lewis Steinberg and Humberto Reboredo (tax) in New York, and Philip Boeckman and Jason Lees in London, and by David Fidler and David Stern (bankruptcy) of Klee, Tuchin, Bogdanoff & Stern LLP in Los Angeles; and in Switzerland by Bourgeois Muller Pidoux & Partners, with a team that included Luc André and Jean-Luc Chenaux in Lausanne. IsoTis’s financial advisors were Frank Manzella of Asanté Partners LLC in New York and California and ABN AMRO Bank N.V. in Amsterdam.

GenSci was represented in Canada by McCullough O’Connor Irwin in Vancouver, with a team led by Jonathan McCullough, Kevin Hisko, Gillian Case, David Gunasekera and Michael Wasylynchuk; by Patrick Sullivan (litigation) of Taylor, Veinotte, Sullivan in Vancouver; and by Frank Quo Vadis (tax) of Koffman Kalef in Vancouver. In the U.S. GenSci was represented by Gary Tober and Ada Ko (tax) of Lane Powell Spears Lubersky LLP in Seattle; and by Brad Wiggins (securities) of Miller & Holguin in Los Angeles. GenSci’s financial advisor was Stirling Mercantile Corporation, and its special committee was represented by Iain Mant of Fasken Martineau DuMoulin LLP in Vancouver.